April 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

April 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

We're sorry, but all tickets sales have ended because the event is expired.
  • April 8, 2021 - April 12, 2021
    6:30 pm

 

You’re invited to join our April 2021 Meeting!

Title
Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

Presented by
Jessica Hart, PharmD, BCACP –
Medical Science Liaison,
Cardiovascular and Metabolic –
North Texas, Oklahoma, AstraZeneca

When
Thursday, April 8, 2021 at 6:30 PM

This is a VIRTUAL meeting


TPA serves members practicing in all areas of pharmacy, including community, hospitals, long-term care facilities, education, manufacturing and distribution. TPA is an effective and strong voice for all Texas pharmacy professionals in advocacy, continuing education and practice innovation by empowering today’s pharmacists to be effective health-care advisors.

How do I become a DAPA/TPA Member?
To be a DAPA member, remember to choose Dallas Area Pharmacy Association as your AFFILIATE during your registration with the Texas Pharmacy Association.
Follow the prompts of the registration process and choose the following:

How much does it cost to be a DAPA/TPA Member?
Click on this link for details!